ITOS - iTeos Therapeutics

-

$undefined

N/A

(N/A)

iTeos Therapeutics NasdaqGM:ITOS iTeos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer. The company's lead antibody product candidate, belrestotug, an antagonist of T-cell immunoreceptor with Ig and ITIM domains (TIGIT), as well as engages the Fc gamma receptor to activate dendritic cells, natural killer cells, T lymphocytes, and macrophages and to promote the release of cytotoxic granules and antibody-dependent cellular cytotoxicity activity. Its product pipeline also includes inupadenant, a next-generation A2AR antagonist program; EOS-984, a small molecule targeting equilibrative nucleoside transporter 1 (ENT1) to reverse immunosuppression and restore T cell proliferation in the tumor microenvironment; and EOS-215, a monoclonal antibody which antagonizes triggering receptor expressed on triggering receptor expressed on myeloid cells 2. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.

Location: 321 Arsenal Street, Watertown, MA, 02472, United States | Website: https://www.iteostherapeutics.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

-131.4M

Cash

520.4M

Avg Qtr Burn

-24.89M

Short % of Float

12.35%

Insider Ownership

1.14%

Institutional Own.

-

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Belrestotug (EOS-448) + Dostarlimab (doublet) Details
Cancer, Non-small cell lung carcinoma

Failed

Discontinued

Failed

Discontinued

Inupadenant (EOS-850) Details
Cancer, Non-small cell lung carcinoma

Failed

Discontinued

EOS-215 Details
Cancer, Solid tumor/s

Failed

Discontinued

Failed

Discontinued